ZURA BIO LIMITED Unrecognized Tax Benefits
ZURA BIO LIMITED (ZURA) had Unrecognized Tax Benefits of $0 as of 2025-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefits · last filed 2026-03-19
- 2025-12-31: Unrecognized Tax Benefits $0.00.
- 2024-12-31: Unrecognized Tax Benefits $0.00.
- 2022-12-31: Unrecognized Tax Benefits $0.00.
- 2022-09-30: Unrecognized Tax Benefits $0.00.
| Period end | Unrecognized Tax Benefits |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-19 |
| 2024-12-31 | $0.00 10-K · filed 2025-03-25 |
| 2022-12-31 | $0.00 10-K · filed 2023-03-28 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-12 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-13 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-28 |
| 2021-09-30 | $0.00 10-Q/A · filed 2022-04-25 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-27 |
| 2021-03-31 | $0.00 10-Q · filed 2021-08-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |